Levetiracetam Stada

Levetiracetam, the active ingredient in Levetiracetam Stada, is an anticonvulsant presented as an oral tablet for oral use. It treats various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain.

Partial-onset seizures: helps control focal seizures that start in one area of the brain. Generalized tonic‑clonic seizures: reduces the frequency of convulsive seizures affecting both hemispheres. Myoclonic seizures: diminishes brief, shock‑like jerks that can occur in several epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nasopharyngitis: upper respiratory tract infection symptoms. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or severe anxiety. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering. - Multifocal seizures: new seizure types emerging during therapy.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events.

Renal function: adjust dose in patients with impaired kidney function. Psychiatric history: monitor for mood changes or suicidal ideation. Pregnancy status: discuss potential risks as data are limited. Concomitant CNS depressants: use caution as additive sedation may occur. Alcohol consumption: advise moderation to avoid enhanced CNS effects. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam levels. - Phenytoin: may lower levetiracetam exposure. - Phenobarbital: can decrease levetiracetam concentrations. - Rifampicin: strong enzyme inducer that reduces drug exposure. - St. John’s wort: may lower plasma levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives: levetiracetam may reduce hormonal efficacy. - Other antiepileptics: additive CNS effects may require dose adjustment. - Alcohol: increased sedation and dizziness. - Sedative antihistamines: potential for enhanced drowsiness. - Antidepressants: monitor for mood alterations.